Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Crippa JAS, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC, Osório FL, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Passos ADC, Dal Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Koenigkam-Santos M, Santos AC, Busatto Filho G, Hallak JEC. Crippa JAS, et al. Among authors: zuardi aw. Cannabis Cannabinoid Res. 2022 Oct;7(5):658-669. doi: 10.1089/can.2021.0093. Epub 2021 Oct 7. Cannabis Cannabinoid Res. 2022. PMID: 34619044 Free PMC article. Clinical Trial.
Duloxetine in the treatment of panic disorder.
Crippa JA, Zuardi AW. Crippa JA, et al. Among authors: zuardi aw. Int J Neuropsychopharmacol. 2006 Oct;9(5):633-4. doi: 10.1017/S1461145705006206. Epub 2005 Nov 17. Int J Neuropsychopharmacol. 2006. PMID: 16288682 Free article. No abstract available.
Cannabidiol monotherapy for treatment-resistant schizophrenia.
Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA. Zuardi AW, et al. J Psychopharmacol. 2006 Sep;20(5):683-6. doi: 10.1177/0269881106060967. Epub 2006 Jan 9. J Psychopharmacol. 2006. PMID: 16401651 Clinical Trial.
Psychometric properties of the Fagerström Test for Nicotine Dependence.
Meneses-Gaya IC, Zuardi AW, Loureiro SR, Crippa JA. Meneses-Gaya IC, et al. Among authors: zuardi aw. J Bras Pneumol. 2009 Jan;35(1):73-82. doi: 10.1590/s1806-37132009000100011. J Bras Pneumol. 2009. PMID: 19219334 Free article. Review. English, Portuguese.
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus.
Fortunato JJ, Réus GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, Pinto JP, Hallak JE, Zuardi AW, Crippa JA, Quevedo J. Fortunato JJ, et al. Among authors: zuardi aw. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1425-30. doi: 10.1016/j.pnpbp.2009.07.021. Epub 2009 Jul 24. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19632287 Free article.
Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties.
Fortunato JJ, Réus GZ, Kirsch TR, Stringari RB, Fries GR, Kapczinski F, Hallak JE, Zuardi AW, Crippa JA, Quevedo J. Fortunato JJ, et al. Among authors: zuardi aw. Brain Res Bull. 2010 Mar 16;81(4-5):491-6. doi: 10.1016/j.brainresbull.2009.09.008. Epub 2009 Sep 20. Brain Res Bull. 2010. PMID: 19772900
224 results